论文部分内容阅读
1983年以来,用0.1％普鲁卡因静脉点滴,治疗难治性支气管哮喘32例,均为用一般茶硷类、激素及β_2受体兴奋剂等治疗未缓解的支气管哮喘,取得了较好疗效,现报道如下。 临床资料 男15例,女17例。年龄26～71岁.外源性哮喘8例,内源性哮喘10例,混合性哮喘14例;合并肺气肿肺心病者23例;重度哮喘20例,哮喘持续状态6例。 治疗方法 对一般药物效果不佳的顽固支气管哮喘,给予0.1％普鲁卡因30ml静滴,每日一次,滴速为30滴/分钟。先做皮肤过敏试验。10天为一疗程。治疗期间停用激素,其他对症治疗不变, 结果 显效:(用药后哮喘症状缓解,哮鸣音消失,血气恢复正常)17例,占53.1％,有效:(症状体征部分缓解)8例,占25.0％,总有效
Since 1983, 0.1% procaine intravenous drip treatment of refractory bronchial asthma in 32 cases, are with the general theophylline, hormones and β_2 receptor agonist treatment of undigested bronchial asthma, and achieved better Efficacy, are reported below. Clinical data of 15 males and 17 females. Aged 26 to 71. Exogenous asthma in 8 cases, 10 cases of endogenous asthma, mixed asthma in 14 cases; pulmonary heart disease with pulmonary heart disease in 23 cases; severe asthma in 20 cases, 6 cases of asthma persistence. Treatment of stubborn bronchial asthma for the general drug ineffective, given 0.1% procaine 30ml intravenous drip once a day, the drip rate of 30 drops / minute. First skin allergy test. 10 days for a course of treatment. 17 cases, accounting for 53.1%, effective: (symptoms and signs of partial remission) in 8 cases, accounting for 25.0%, always effective